TRAW- Traws Pharma, Inc.

Name: Traws Pharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Traws Pharma, Inc. (TRAW) has 11 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. TRAW is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Orbimed Advisors LLC	1.79M	$3.05M	+3.59M
COO	Savchuk Nikolay	150.6K	$256.0K	-
CEO	Dukes Iain D.	147.8K	$251.2K	-
Other	Pauza Charles David	116.0K	$197.2K	-
Other	Redfield Robert	113.9K	$193.7K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 16, 2026	Orbimed Advisors LLC67	10% Owner	Buy	597,729	$1.67	$998,207.43	+98.7%	-	-
Jan 28, 2022	Oler Abraham N.	SVP Corp Dev &Gen Counsel	Buy	1,500	$1.67	$2,505.00	+6.5%	-19.0%	-51.1%
Jan 21, 2022	Oler Abraham N.	SVP Corp Dev &Gen Counsel	Buy	1,500	$2.02	$3,030.00	+7.0%	-22.7%	-55.6%
Jan 14, 2022	Oler Abraham N.	SVP Corp Dev &Gen Counsel	Buy	1,500	$2.20	$3,300.00	+7.5%	-27.5%	-60.4%
Jan 7, 2022	Oler Abraham N.	SVP Corp Dev &Gen Counsel	Buy	1,500	$2.39	$3,585.00	+8.1%	-23.5%	-68.7%
Nov 19, 2021	Oler Abraham N.	SVP Corp Dev &Gen Counsel	Buy	1,000	$3.16	$3,160.00	+5.7%	-48.1%	-69.3%
Sep 28, 2021	Marino James J	Director	Buy	5,952	$4.20	$24,998.40	+38.7%	-28.1%	-74.8%
Sep 28, 2021	Oler Abraham N.	SVP Corp Dev &Gen Counsel	Buy	2,381	$4.20	$10,000.20	+23.5%	-28.1%	-74.8%
Sep 28, 2021	Gelder Mark S. Md	Chief Medical Officer	Buy	2,381	$4.20	$10,000.20	New	-28.1%	-74.8%
Sep 28, 2021	Fruchtman Steven M	President, Chief Executive Off	Buy	2,381	$4.20	$10,000.20	+15.1%	-28.1%	-74.8%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC